Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Feb-26-22 | Feb-27-21 | Feb-29-20 | Mar-02-19 | Mar-03-18 | Mar-04-17 | Feb-27-16 | Feb-28-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Retail Pharmacy | 17,494.8 | 16,365.3 | 15,616.2 | 15,757.2 | 15,832.6 | 16,766.6 | 16,820.4 | 26,528.4 |
Pharmacy Services | 7,323.1 | 7,970.1 | 6,559.6 | 6,093.7 | 5,896.7 | 6,393.9 | 4,103.5 | |
Total revenues | 24,568.3 | 24,043.2 | 21,928.4 | 21,639.6 | 21,529.0 | 22,927.5 | 20,770.2 | 26,528.4 |
Revenue growth [+] | 2.2% | 9.6% | 1.3% | 0.5% | -6.1% | 10.4% | -21.7% | 3.9% |
Retail Pharmacy | 6.9% | 4.8% | -0.9% | -0.5% | -5.6% | -0.3% | -36.6% | 3.9% |
Pharmacy Services | -8.1% | 21.5% | 7.6% | 3.3% | -7.8% | 55.8% | | |
Unit growth | 34900.0% | -99.7% | -0.3% | -3.2% | -43.8% | -0.5% | -0.2% | -0.4% |
Cost of goods sold | 19,461.8 | 19,338.9 | 17,201.6 | 16,963.2 | 16,748.9 | 17,862.8 | 15,778.3 | 18,951.6 |
Gross profit | 5,106.5 | 4,704.3 | 4,726.8 | 4,676.4 | 4,780.1 | 5,064.7 | 4,992.0 | 7,576.7 |
Gross margin | 20.8% | 19.6% | 21.6% | 21.6% | 22.2% | 22.1% | 24.0% | 28.6% |
Selling, general and administrative | 5,033.9 | 4,657.2 | 4,587.3 | 4,592.4 | 4,651.3 | 4,777.0 | 4,581.2 | 6,695.6 |
Other operating expenses | 17.3 | -97.7 | -107.2 | -41.6 | -350.9 | -6.6 | 65.8 | -3.8 |
Adjusted EBITDA | 364.0 | 485.0 | 590.9 | 495.6 | 891.6 | 725.2 | 744.1 | 1,324.9 |
Adjusted EBITDA margin | 1.5% | 2.0% | 2.7% | 2.3% | 4.1% | 3.2% | 3.6% | 5.0% |
Stock-based compensation | 13.1 | 13.0 | 16.1 | 12.1 | 25.8 | 23.5 | 37.9 | 23.4 |
EBITDA [+] | 351.0 | 472.0 | 574.9 | 483.5 | 865.8 | 701.7 | 706.1 | 1,301.5 |
EBITDA growth | -25.6% | -17.9% | 18.9% | -44.2% | 23.4% | -0.6% | -45.7% | 10.1% |
EBITDA margin | 1.4% | 2.0% | 2.6% | 2.2% | 4.0% | 3.1% | 3.4% | 4.9% |
Depreciation | 217.6 | 238.1 | 224.3 | 232.2 | 238.3 | 241.8 | 229.8 | 298.5 |
EBITA | 133.3 | 233.9 | 350.5 | 251.2 | 627.5 | 459.9 | 476.4 | 1,003.0 |
EBITA margin | 0.5% | 1.0% | 1.6% | 1.2% | 2.9% | 2.0% | 2.3% | 3.8% |
Amortization of intangibles | 78.0 | 89.0 | 103.9 | 125.6 | 147.7 | 165.6 | 131.4 | 118.1 |
EBIT [+] | 55.3 | 144.8 | 246.6 | 125.6 | 479.7 | 294.4 | 345.0 | 884.9 |
EBIT growth | -61.8% | -41.3% | 96.3% | -73.8% | 63.0% | -14.7% | -61.0% | 13.7% |
EBIT margin | 0.2% | 0.6% | 1.1% | 0.6% | 2.2% | 1.3% | 1.7% | 3.3% |
Non-recurring items [+] | 409.2 | 58.4 | 42.8 | 487.9 | 320.5 | 45.8 | 40.5 | 41.9 |
Asset impairment | 409.2 | 58.4 | 42.8 | 483.2 | 320.5 | 45.8 | 40.5 | 41.9 |
Interest expense | 191.6 | 201.4 | 229.7 | 227.7 | 202.8 | 200.1 | 186.1 | 397.6 |
Interest expense | 191.6 | 201.4 | 229.7 | 227.7 | 202.8 | 200.1 | 186.1 | 397.6 |
Other income (expense), net [+] | 3.2 | -5.3 | -55.7 | 0.6 | | | 33.2 | -18.5 |
Gain (loss) on sale of assets | 5.5 | -69.3 | 4.2 | -38.0 | -25.9 | -6.6 | -0.6 | -3.8 |
Gain (loss) on debt retirement | -3.2 | 5.3 | 55.7 | -0.6 | | | -33.2 | 18.5 |
Pre-tax income | -542.3 | -120.2 | -81.6 | -589.5 | -43.5 | 48.5 | 151.6 | 426.8 |
Income taxes | -3.8 | -20.2 | 387.6 | 77.5 | 306.0 | 44.4 | 49.5 | -1,682.4 |
Tax rate | 0.7% | 16.8% | | | | 91.6% | 32.7% | |
Earnings from continuing ops | -538.5 | -100.1 | -469.2 | -911.7 | -1,642.5 | 4.1 | 38.7 | 2,114.6 |
Earnings from discontinued ops | | 9.2 | 17.0 | 244.7 | 1,293.0 | 0.0 | 63.4 | |
Net income | -538.5 | -90.9 | -452.2 | -667.0 | -349.5 | 4.1 | 102.1 | 2,114.6 |
Net margin | -2.2% | -0.4% | -2.1% | -3.1% | -1.6% | 0.0% | 0.5% | 8.0% |
|
Basic EPS [+] | ($9.96) | ($1.87) | ($8.82) | ($17.25) | ($31.30) | $0.08 | $0.04 | $2.18 |
Growth | 434.1% | -78.8% | -48.9% | -44.9% | -39895.4% | 108.1% | -98.3% | 809.2% |
Diluted EPS [+] | ($9.96) | ($1.87) | ($8.82) | ($17.25) | ($31.30) | $0.08 | $0.04 | $2.08 |
Growth | 434.1% | -78.8% | -48.9% | -44.9% | -40520.3% | 108.5% | -98.2% | 820.9% |
|
Shares outstanding (basic) [+] | 54.1 | 53.7 | 53.2 | 52.9 | 52.5 | 52.2 | 1,024.4 | 971.1 |
Growth | 0.7% | 0.8% | 0.7% | 0.7% | 0.5% | -94.9% | 5.5% | 5.3% |
Shares outstanding (diluted) [+] | 54.1 | 53.7 | 53.2 | 52.9 | 52.5 | 53.0 | 1,042.4 | 1,017.9 |
Growth | 0.7% | 0.8% | 0.7% | 0.7% | -1.1% | -94.9% | 2.4% | 4.0% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|